Table 2.

Mean ± Standard deviation differences of Escudier et al. scores throughout the study period

	Site score		Severity score		Activity score
	Lycopene group (n = 10)	Corticosteroids group (n = 10)	Lycopene group (n = 10)	Corticosteroids group (n = 10)	Lycopene group (n = 10)	Corticosteroids group (n = 10)
Baseline	4.50 ± 2.12a,b	3.40 ± 1.58a	4.70 ± 3.09a	5.90 ± 2.23a	7.70 ± 4.27a	8.20 ± 3.94a
Week 4	3.50 ± 1.78a,b	2.10 ± 1.00b	3.30 ± 2.91a,b	3.10 ± 2.51b	4.40 ± 3.37a,b	3.10 ± 2.bb
Week 8	3.30 ± 1.83a,b	1.90 ± 0.88b	1.70 ± 1.95b	2.30 ± 1.70b	2.00 ± 2.26b	2.30 ± 1.70b
Friedman test p value	p < 0.001*	p < 0.001*	p < 0.001*	p < 0.001*	p < 0.001*	p < 0.001*

^a,bDifferent superscripted letters denote statistically significant differences between different assessment times in each group using Bonferroni adjustment

n, number of patients

*Statistically significant at p value < 0.05